Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
An in vitro hepatitis C virus (HCV) replication system that is capable of producing viral particles in a culture medium More
Prevention of Hydrocephalus. The supplement is a dual-combination therapy comprising safe, natural compounds. More
2. Anti-Atopic Dermatitis Cosmetics, Anti-Acne Cosmetics, Anti-Oxidants Vitaplus More
HUMAN PANCREATIC PROGENITOR CELL LINES More
The NF-kB pathway is associated with a variety of diseases such as cancer and diabetes. Many of these diseases do not currently have any effective therapies available. The lead compound 13-197 is a novel molecule for inhibiting the NF-kB pathway that is More
Development of broad spectrum anti-viral agent using body-derived virus suppressing factor, activati More
A novel microbe strain (patent pending), inhibits absorption of fat in the gastrointestinal tract, reducing calorie intake More
Risk Prediction for Hypertension, Elevated Plasma Triglyceride and Metabolic Syndrome: Elucidation of A Common LPL Haplotype More
Novel Assay for the Identification of Therapeutic Agents that Prevent or Treat Diseases Involving Oxidative Stress More
Genetic Association of Familial Combined Hyperlipidaemia for Diagnostic and Pharmacogenomic uses More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2010 - 160 pages - $3,995
Jan 2011 - 99 pages - $3,835
Aug 2010 - 80 pages - $1,215
Aug 2007 - 87 pages - $1,999
Mar 2011 - 23 pages - $250
Sep 2010 - 21 pages - $99
Aug 2010 - 138 pages - $1,215
Feb 2010 - 131 pages - $3,835
Aug 2008 - 117 pages - $2,350
Jun 2010 - 411 pages - $2,695
Your selection
Browse By
- Industry sector
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us